BRCA1 and ovarian carcinoma: These data indicate that, although a germline deletion of CYP2A7 may protect against initiation of ovarian cancer in the context of a BRCA1 germline pathogenic variant, somatic deletions of CYP2A7 may be important for the ovarian cancer development or progression.